UPDATE 2-Bristol Myers posts quarterly loss, revenue rises 5%

Bristol Myers Squibb on Thursday reported a first-quarter loss as charges related to its recent acquisitions of Karuna Therapeutics, RayzeBio and Mirati Therapeutics offset a 5% increase in revenue. The New Jersey-based drugmaker posted a loss of $4.40 per share, including charges for acquired…#bristolmyerssquibb #karunatherapeutics #rayzebio #miratitherapeutics #newjersey #bristol #pfizer #opdualag #opdivo #bristolmyers
Source: Reuters: Health - Category: Consumer Health News Source Type: news